BIANCHI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 7.331
EU - Europa 3.657
AS - Asia 2.884
SA - Sud America 352
AF - Africa 58
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 11
Totale 14.305
Nazione #
US - Stati Uniti d'America 7.233
GB - Regno Unito 1.253
IT - Italia 865
SG - Singapore 859
CN - Cina 811
HK - Hong Kong 477
SE - Svezia 427
BR - Brasile 285
DE - Germania 259
VN - Vietnam 198
RU - Federazione Russa 184
FR - Francia 155
TR - Turchia 127
UA - Ucraina 124
FI - Finlandia 107
KR - Corea 95
CA - Canada 75
ID - Indonesia 72
IN - India 58
BG - Bulgaria 47
IR - Iran 38
NL - Olanda 38
JP - Giappone 37
SI - Slovenia 27
AR - Argentina 26
PL - Polonia 25
LT - Lituania 24
ZA - Sudafrica 23
BE - Belgio 22
CZ - Repubblica Ceca 18
BD - Bangladesh 16
QA - Qatar 15
EC - Ecuador 14
ES - Italia 14
IQ - Iraq 14
IE - Irlanda 13
MX - Messico 13
EG - Egitto 11
AU - Australia 10
CH - Svizzera 10
EU - Europa 9
TW - Taiwan 9
CO - Colombia 8
MY - Malesia 8
AE - Emirati Arabi Uniti 7
AT - Austria 7
CL - Cile 7
UZ - Uzbekistan 7
LU - Lussemburgo 6
MA - Marocco 6
PK - Pakistan 6
SA - Arabia Saudita 6
DK - Danimarca 4
GR - Grecia 4
KE - Kenya 4
NO - Norvegia 4
PT - Portogallo 4
RO - Romania 4
AL - Albania 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
IL - Israele 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
BW - Botswana 2
EE - Estonia 2
JM - Giamaica 2
KW - Kuwait 2
LB - Libano 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
CD - Congo 1
CR - Costa Rica 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MN - Mongolia 1
MT - Malta 1
NG - Nigeria 1
OM - Oman 1
Totale 14.299
Città #
Southend 949
Fairfield 818
Ashburn 753
Santa Clara 634
Singapore 539
Chandler 464
Hong Kong 464
Woodbridge 428
Houston 400
Seattle 305
Cambridge 280
Wilmington 257
Ann Arbor 249
Nyköping 215
Modena 200
Dearborn 199
Jacksonville 190
Hefei 187
London 162
Beijing 154
Los Angeles 131
Chicago 112
New York 102
Seoul 85
San Diego 74
Izmir 71
Jakarta 62
Ho Chi Minh City 56
Milan 55
Salt Lake City 51
Council Bluffs 50
Shanghai 50
Munich 49
Princeton 49
Fremont 48
Sofia 47
Helsinki 45
Eugene 44
Bologna 42
The Dalles 39
Shenzhen 38
Hanoi 37
Reggio Emilia 37
Sant'Ilario d'Enza 36
Moscow 34
São Paulo 33
Tampa 32
Buffalo 31
Rome 30
Elk Grove Village 29
Montreal 27
Tokyo 26
Turku 26
Dong Ket 25
Dallas 24
Phoenix 24
Toronto 24
Bremen 22
Des Moines 22
Frankfurt am Main 20
Hillsboro 20
Redwood City 20
Brussels 19
Columbus 18
Boardman 17
Parma 17
Johannesburg 16
Nuremberg 16
Poplar 16
Falls Church 15
Doha 14
Orem 14
Florence 13
Guangzhou 13
Warsaw 13
Atlanta 12
Dublin 12
Sterling 12
Belo Horizonte 11
Chennai 11
Denver 11
Miami 11
Naples 11
Brno 10
Palermo 10
Haiphong 9
Jinan 9
Lancaster 9
Las Vegas 9
Lauterbourg 9
Paris 9
Rio de Janeiro 9
Turin 9
Detroit 8
Manchester 8
Monmouth Junction 8
Redondo Beach 8
Shenyang 8
Stockholm 8
Amsterdam 7
Totale 10.165
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 498
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 452
c-Myb supports erythropoiesis by transactivating KLF1 and LMO2 expression 392
C-Myb Restrains Megakaryopoiesis through the Hsa-MiR-486-3p-Driven Down-Regulation of C-Maf 374
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 374
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice 372
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 371
miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1 349
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1) 343
Co-culture of hematopoietic stem/progenitor cells with human osteblasts favours mono/macrophage differentiation at the expense of the erythroid lineage 334
Eosinophils, but not neutrophils, exibit an efficient DNA repair machinary and high nucleolar activity 330
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 328
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 318
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 318
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 315
Genomic landscape of megakaryopoiesis and platelet function defects 306
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 306
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 305
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 302
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 299
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 298
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 295
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 293
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 275
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 271
HGM 2010 Programme / Abstract 259
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 258
Regulatory Mrna/Microrna Networks in CD34+ Cells From Primary Myelofibrosis 250
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cells 245
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-miR-299-5p in CD34+ progenitor cells commitment 241
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib 230
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 227
Molecular and functional characterization of CD133+ stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 226
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis 214
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 212
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 212
IDENTIFICATION OF A MOLECULAR SIGNATURE PREDICTIVE OF REFRACTORINESS IN ACUTE MYELOID LEUKEMIA 211
Regulatory mRNA/microRNA networks in CD34+ cells from Primary Myelofibrosis 209
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoieis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 207
Genomic analysis of hematopoietic stem cell at the single-cell level: Optimization of cell fixation and whole genome amplification (WGA) protocol 205
Abnormal expression of WT1-as, MEG3 and ANRIL long non-coding RNAs in primary myelofibrosis and their clinical correlates 204
Regulatory mRNA/microRNA networks in CD34+ cells from Primary Myelofibrosis 203
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 200
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis 191
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 191
Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells. the crucial role of PTEN. 185
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 181
Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis 176
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 166
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis 158
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis 153
Comparison between Cultivated Oral Mucosa and Ocular Surface Epithelia for COMET Patients Follow-Up 153
MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF 146
Silencing CD34 antigen in human hematopoietic stem cells 144
Targeting exhausted cytotoxic T cells through CTLA‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts 120
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis 40
Totale 14.435
Categoria #
all - tutte 55.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.004


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021990 0 0 0 0 0 135 137 159 98 206 148 107
2021/20221.191 57 97 143 72 58 77 51 78 119 95 189 155
2022/20231.520 172 192 135 131 190 167 29 135 159 34 74 102
2023/20241.078 49 47 83 112 146 77 200 126 10 31 60 137
2024/20252.899 83 28 50 164 574 451 262 210 264 123 354 336
2025/20262.649 374 182 352 614 984 143 0 0 0 0 0 0
Totale 14.435